United States News Todas as matérias

Leidos (NYSE:LDOS) reported third-quarter 2026 revenue of $4.63 billion, up 4% year over year, while net income increased 12% to $413 million.

Teva Pharmaceutical Industries (NYSE:TEVA) signed an agreement with Samsung Bioepis to commercialize two FDA-approved biosimilars in the United States, expanding its immunology portfolio.

Yum China (NYSE:YUMC) reported third-quarter 2026 revenue of $3.477 billion, up 8% year over year, as operating profit increased 13% to $451 million.

Tesla (NASDAQ:TSLA) reported a 10.3% year-over-year increase in China-made electric vehicle sales to 67,829 units in October 2026, according to data from the China Passenger Car Association.

TotalEnergies (NYSE:TTE) signed a five-year agreement with ADNOC Gas for the supply of up to 1.6 million tonnes of liquefied natural gas, expanding their existing commercial relationship.

Brent crude rose 1.76% to $106.61 per barrel on Tuesday as US strikes on Iran's Qeshm Island renewed concerns about Middle East oil supplies.

ADTRAN Holdings (NASDAQ:ADTN) reported third-quarter 2026 revenue of $281.2 million, up 0.6% year over year, while recording a GAAP diluted loss of $0.10 per share.

WISeQey (NASDAQ:WQEY) reported preliminary unaudited revenue of $17 million for the first nine months of 2026, up 55% year over year, primarily supported by subsidiary SEALSQ.

Philips (NYSE:PHG) reported third-quarter 2026 sales of approximately €4.4 billion, with comparable sales increasing 3% and order intake rising 8%, supported by growth in its healthcare technology businesses.

Blue Moon Metals (NASDAQ:BMM) signed an agreement to sell Blue Moon Norway to ACG Metals for approximately $220 million in shares, transferring its Norwegian copper development interests.

BETA Technologies (NYSE:BETA) reported third-quarter 2026 revenue of $17.7 million, up 98% year over year, exceeding company guidance as electric aircraft operations and commercial activities expanded.

Apple (NASDAQ:AAPL) reported fiscal fourth-quarter 2026 revenue of $114.5 billion, up 12% year over year, as iPhone and Services performance supported quarterly growth.

Palantir Technologies (NASDAQ:PLTR) reported third-quarter 2026 revenue of $2.313 billion, up 96% year over year, as U.S. commercial sales surpassed government revenue for the first time.

Vertex Pharmaceuticals (NASDAQ:VRTX) reported third-quarter 2026 revenue of $3.44 billion, up 12% year over year, and raised its full-year revenue guidance to $13.15 billion–$13.25 billion.

Oracle (NYSE:ORCL) shares fell 6.2% to $122.61 in early trading on Monday after the company disclosed plans to raise $20 billion through stock and bond offerings to support its financial and investment requirements.

Axsome Therapeutics (NASDAQ:AXSM) reported a third-quarter 2026 net loss of $12.9 million, or $0.25 per share, beating analyst expectations for a loss of $0.69 per share.

Marvell Technology (NASDAQ:MRVL) agreed to acquire Lumentum (NASDAQ:LITE) in an all-stock transaction with an implied enterprise value of $115 billion, combining semiconductor and optical technologies for AI infrastructure.

Alexander's (NYSE:ALX) reported third-quarter 2026 funds from operations of $36.3 million, or $7.07 per share, while revenue reached $72.1 million.

Pathfinder Bancorp (NASDAQ:PBHC) reported third-quarter 2026 net income of $2.1 million, compared with $0.7 million a year earlier, while diluted earnings per share increased to $0.32 from $0.10.

Tower Semiconductor (NASDAQ:TSEM) reported record third-quarter 2026 revenue of $526.2 million, up 33% year over year, as net profit attributable to the company increased to $120.3 million.

Acadia Realty Trust (NYSE:AKR) reported third-quarter 2026 same-property net operating income growth of 10.2%, supported by stronger street retail performance, while adjusted funds from operations increased to $0.31 per share.

Fox Corporation (NASDAQ:FOXA) reported fiscal first-quarter 2027 revenue of $4.57 billion, up 22% year over year, as higher advertising and distribution revenue supported stronger earnings.

Krystal Biotech (NASDAQ:KRYS) reported third-quarter 2026 VYJUVEK net revenue of $127.3 million, up 30% year over year, while maintaining a gross margin of 94%.

TAT Technologies (NASDAQ:TATT) reported third-quarter 2026 revenue of $55.6 million, up 20.2% year over year, as stronger business activity supported higher profitability and earnings.